FDA Approved: FLUDEOXYGLUCOSE F18 — Original Application (The University of Texas MD Anderson Cancer Center)

View source ↗

Summary

FDA approved the original application for FLUDEOXYGLUCOSE F18, a PET imaging radiopharmaceutical developed by The University of Texas MD Anderson Cancer Center …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Fludeoxyglucose F18 (Fludeoxyglucose F18)

Snippet

ORIG AP for FLUDEOXYGLUCOSE F18 (FLUDEOXYGLUCOSE F18)